Work

The Integration of Chemotherapy and Surgery for Bladder Cancer

Year: 2005

Type: article

Abstract: Despite surgery with curative intent, approximately 50% of patients with muscle-invasive transitional cell carcinoma of the bladder will develop distant metastases and succumb to their disease. Attempts to improve outcomes have focused on refining surgical techniques and integrating perioperative chemotherapy. This review summarizes the available literature addressing the role of pelvic lymphadenectomy, neoadjuvant chemotherapy, and adjuvant chemotherapy in the management of patients with muscle-invasive transitional cell carcinoma of bladder.

Source: Journal of the National Comprehensive Cancer Network

DOI: 10.6004/jnccn.2005.0003

Authors: Matthew D. Galsky, Harry W. Herr, Dean F. Bajorin

Institutions: Memorial Sloan Kettering Cancer Center, Cornell University

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Bristol-Myers Squibb, Eli Lilly and Company